Franklin Resources
HBIO icon

Franklin Resources’s Harvard Bioscience HBIO Stock Holding History

Franklin Resources’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,666
Closed -$35.2K – 3015
2024
Q4 		$35.2K Hold
1,666
– – ﹤0.01% 2828
2024
Q3 		$41.5K Buy
1,666
+10
+0.6% +$295 ﹤0.01% 2811
2024
Q2 		$47.2K Buy
1,656
+32
+2% +$1.12K ﹤0.01% 2737
2024
Q1 		$68.9K Hold
1,624
– – ﹤0.01% 2747
2023
Q4 		$86.9K Buy
1,624
+59
+4% +$2.66K ﹤0.01% 2484
2023
Q3 		$67.3K Buy
+1,565
New +$72.2K ﹤0.01% 2506

Other funds holding HBIO

AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources's HBIO Position: Q1 2025 in Review

Franklin Resources sold out of Harvard Bioscience (HBIO) in Q1 2025, closing a stake of 1,666 shares — an estimated $35.2K sold.

Franklin Resources first reported a position in HBIO in Q3 2023 and held it in 6 quarters. The position peaked at $86.9K in Q4 2023. 91 funds tracked by Wall St. Rank hold HBIO as of Q1 2025.

  • Franklin Resources reported no remaining Harvard Bioscience position as of Q1 2025 after selling out during the quarter.
  • Franklin Resources sold 1,666 Harvard Bioscience shares in Q1 2025, an estimated $35.2K.
  • Franklin Resources first reported a position in Harvard Bioscience in Q3 2023 and held it in 6 quarters.
  • Franklin Resources's Harvard Bioscience position peaked at $86.9K in Q4 2023.
  • 91 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2025.

Based on Franklin Resources's 13F filing for Q1 2025, filed 13 May 2025.